The article found that MYBL2 was a downstream target of miR‐30c‐2‐3p and was highly expressed in LUAD tissues with the capable of predicting a poor prognosis, which was consistent with the studies in esophageal squamous cell carcinoma (25), HCC (26) and pancreatic ductal carcinoma (27). This evidence concerns the gene MYBL2 and pancreatic ductal adenocarcinoma.